» Articles » PMID: 28671185

A Point-of-care Microfluidic Biochip for Quantification of CD64 Expression from Whole Blood for Sepsis Stratification

Overview
Journal Nat Commun
Specialty Biology
Date 2017 Jul 4
PMID 28671185
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis, a potentially life-threatening complication of an infection, has the highest burden of death and medical expenses in hospitals worldwide. Leukocyte count and CD64 expression on neutrophils (nCD64) are known to correlate strongly with improved sensitivity and specificity of sepsis diagnosis at its onset. A major challenge is the lack of a rapid and accurate point-of-care (PoC) device that can perform these measurements from a minute blood sample. Here, we report a PoC microfluidic biochip to enumerate leukocytes and quantify nCD64 levels from 10 μl of whole blood without any manual processing. Biochip measurements have shown excellent correlation with the results from flow cytometer. In clinical studies, we have used PoC biochip to monitor leukocyte counts and nCD64 levels from patients' blood at different times of their stay in the hospital. Furthermore, we have shown the biochip's utility for improved sepsis diagnosis by combining these measurements with electronic medical record (EMR).

Citing Articles

Micropump integrated white blood cell separation platform for detection of chronic granulomatous disease.

Mane S, Behera A, Hemadri V, Bhand S, Tripathi S Mikrochim Acta. 2024; 191(5):295.

PMID: 38700804 DOI: 10.1007/s00604-024-06372-7.


Enabling biomedical technologies for chronic myelogenous leukemia (CML) biomarkers detection.

Pinnenti M, Sami M, Hassan U Biomicrofluidics. 2024; 18(1):011501.

PMID: 38283720 PMC: 10817778. DOI: 10.1063/5.0172550.


Multiplexed electrical detection of whole viruses from plasma in a microfluidic platform.

Jankelow A, Chen C, Cowell T, Espinosa de Los Monteros J, Bian Z, Kindratenko V Analyst. 2024; 149(4):1190-1201.

PMID: 38213181 PMC: 11646553. DOI: 10.1039/d3an01510f.


Multi-modal sensing with integrated machine learning to differentiate specific leukocytes targeted by electrically sensitive hybrid particles.

Ashley B, Sui J, Javanmard M, Hassan U Biosens Bioelectron. 2023; 241:115661.

PMID: 37690356 PMC: 10977608. DOI: 10.1016/j.bios.2023.115661.


Electrochemical point-of-care devices for the diagnosis of sepsis.

Valera E, Kindratenko V, Jankelow A, Heredia J, Kim A, Cowell T Curr Opin Electrochem. 2023; 39.

PMID: 37483649 PMC: 10357885. DOI: 10.1016/j.coelec.2023.101300.


References
1.
Repp R, Valerius T, Sendler A, Gramatzki M, Iro H, Kalden J . Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood. 1991; 78(4):885-9. View

2.
Adams A, Okagbare P, Feng J, Hupert M, Patterson D, Gottert J . Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J Am Chem Soc. 2008; 130(27):8633-41. PMC: 2526315. DOI: 10.1021/ja8015022. View

3.
Conway D, Sakurai Y, Weiss D, Vega J, Taylor W, Jo H . Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress. Cardiovasc Res. 2009; 81(4):669-77. PMC: 2642602. DOI: 10.1093/cvr/cvn360. View

4.
Cheng X, Irimia D, Dixon M, Ziperstein J, Demirci U, Zamir L . A microchip approach for practical label-free CD4+ T-cell counting of HIV-infected subjects in resource-poor settings. J Acquir Immune Defic Syndr. 2007; 45(3):257-61. DOI: 10.1097/QAI.0b013e3180500303. View

5.
Du J, Li L, Dou Y, Li P, Chen R, Liu H . Diagnostic utility of neutrophil CD64 as a marker for early-onset sepsis in preterm neonates. PLoS One. 2014; 9(7):e102647. PMC: 4102545. DOI: 10.1371/journal.pone.0102647. View